| | |
SCHEDULE 13G |
CUSIP No. G5870E132 | | Page 7 of 11 Pages |
Mars Acquisition Corp. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices |
Americas Tower, 1177 Avenue of The Americas, Suite 5100, New York, NY 10036
Item 2(a). | Names of Persons Filing |
This Statement is filed on behalf of the following persons (collectively, the “Reporting Persons”):
| i) | Harraden Circle Investors, LP (“Harraden Fund”); |
| ii) | Harraden Circle Investors GP, LP (“Harraden GP”); |
| iii) | Harraden Circle Investors GP, LLC (“Harraden LLC”); |
| iv) | Harraden Circle Investments, LLC (“Harraden Adviser”); and |
| v) | Frederick V. Fortmiller, Jr. (“Mr. Fortmiller”); |
This Statement relates to Shares (as defined herein) directly beneficially owned by Harraden Fund. Harraden GP is the general partner to Harraden Fund, and Harraden LLC is the general partner of Harraden GP. Harraden Adviser serves as investment manager to Harraden Fund and other high net worth individuals. Mr. Fortmiller is the managing member of each of Harraden LLC and Harraden Adviser. In such capacities, each of Harraden GP, Harraden LLC, Harraden Adviser and Mr. Fortmiller may be deemed to indirectly beneficially own the Shares reported herein directly beneficially owned by Harraden Fund.
Item 2(b). | Address of Principal Business Office or, if None, Residence |
The address of the principal business office of each Reporting Person is 299 Park Avenue, 21st Floor, New York, NY 10171.
Each of Harraden Fund and Harraden GP is a Delaware limited partnership. Each of Harraden LLC and Harraden Adviser is a Delaware limited liability company. Mr. Fortmiller is a citizen of the United States of America.
Item 2(d). | Title of Class of Securities |
Class A Common Stock, par value $0.0001 per share (“Shares”)
Item 2(e). | CUSIP No. G5870E132 |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
This Item 3 is not applicable.